The Bowel Cancer Data Younger Australians Can No Longer Ignore

Josh Collins was 36 when he was diagnosed with bowel cancer in 2020. He hosts a mining industry podcast, works in a sector whose typical worker sits squarely in his late thirties or early forties, and he was, by the standard assumption, far too young to have this disease.

That assumption is now the problem. The steepest rise in bowel cancer incidence in Australia is happening in exactly the age band the resources workforce occupies.

Cases in Australians under 50 have more than doubled since 2000. The rate in the 30-39 age group has tripled. Australia and New Zealand carry the highest lifetime risk of bowel cancer of any region on the planet.

For a workforce of working-age adults spread across remote sites, long rosters, and fly-in fly-out schedules, this is not a distant public health headline. It is a data trend that overlaps precisely with the people reading this.

What follows here is practical orientation for anyone in the 35-55 window who has never framed bowel cancer as a personal concern: what the rising numbers among younger Australians actually mean, what changed in the national screening programme in 2024, and where the specific friction points sit for workers in remote and FIFO contexts.

The numbers that explain why a 36-year-old’s diagnosis is no longer a statistical outlier

Look at the trajectory rather than any single figure, and the shift becomes hard to dismiss. In 2000, there were 960 colorectal cancer cases in Australians under 50. By 2024, that estimate had climbed to roughly 2,045. The count more than doubled in a generation, and colon cancer rather than rectal cancer drove most of the increase in younger patients.

The age-band breakdown is where the trend sharpens. The movement is not uniform across younger adults, and the fastest acceleration sits right in the middle of the working-age population.

The 30-39 cohort is the standout: incidence roughly tripled, from 6.3 to an estimated 19 cases per 100,000. Even among 15-24-year-olds, rates rose 266% over three decades, according to national analysis.

The share of all bowel cancer diagnoses occurring in people under 50 tracks the same direction, rising from 8% in 2000 to approximately 13% by 2024, on the Australian Institute of Health and Welfare’s estimate.

The AIHW colorectal cancer data tracks the share of all bowel cancer diagnoses occurring in Australians under 50, rising from 8% in 2000 to approximately 13% by 2024, a trajectory consistent with the steepening incidence curves visible across every younger age band.

Now place Australia in a global frame, because the national baseline is already elevated.

Australia carries the world’s highest lifetime bowel cancer risk. Among 20 global regions, Australia and New Zealand sit at the top for lifetime risk of developing colorectal cancer, estimated at 7.41%. Northern Europe is next at 6.79%. Australia also ranked 4th of 15 comparison countries for incidence in 2022, at 34.6 cases per 100,000.

Here is what that combination tells you. When a disease is trending up fastest in the 30-39 band, and the country you work in already carries the highest baseline risk globally, a diagnosis at 36 stops being a freak event and becomes a foreseeable data point. For a mining workforce where the median worker is in their late thirties or early forties, bowel cancer is no longer something you can reasonably file under “worry about it later.”

What is driving the rise, and why the causes are not what most people assume

The instinct, when cancer rates climb, is to reach for genetics or bad luck. The evidence points somewhere more uncomfortable, and more within reach.

Roughly 50% of early-onset colorectal cancer cases have no identifiable genetic syndrome or clear inherited predisposition. They appear sporadically. Around 30% occur in people with a family history of colorectal cancer or polyps. That leaves the bulk of the rise pointing away from inheritance and toward how younger adults now live, eat, and move.

The leading suspects are consistent across the research:

• Diet: A Westernised pattern high in processed and red meat, fast food, refined carbohydrates, and high sodium is repeatedly implicated.
• Physical inactivity: Sedentary patterns are strongly associated with sporadic early-onset cases.
• Obesity and metabolic factors: Rising obesity, metabolic syndrome, and diabetes track alongside the incidence trend.
• Gut microbiome disruption: Shifts in gut bacteria, driven by modern diets and antibiotic exposure, are proposed as a central mechanism.

Tumour biology in younger patients also appears distinct, and often more aggressive than in older patients, which raises the stakes on early detection specifically for this group.

Here is where it gets complicated for a resources audience. Limited fresh food access on remote sites, disrupted sleep from shift rotations, and sustained physical and psychological load are not incidental lifestyle slip-ups. They are structural features of the job. Several of the modifiable risk factors are, for FIFO and remote workers, harder to modify than the word “modifiable” implies.

Heat stress on mine sites compounds the physiological load workers already carry from shift rotations and disrupted sleep, and both chronic heat exposure and circadian disruption have been linked in emerging research to metabolic dysfunction, one of the proposed drivers behind rising bowel cancer rates in younger adults.

Emerging theories still under investigation

A second tier of hypotheses is gathering evidence without yet reaching the threshold of settled science, and they are worth watching rather than treating as proven.

Certain strains of Escherichia coli produce a toxin called colibactin, and exposure to it has been linked to bowel cancer developing at younger ages. One large synthesis of studies has associated microplastic exposure with colon cancer, though the causal link remains unconfirmed. Stress and circadian rhythm disruption, both familiar territory for shift workers, sit in the same category: noteworthy enough to flag, not established enough to bank on.

The read you should take is this. The rise is not primarily a genetic story, which means a meaningful share of the risk connects to patterns of eating, movement, and gut health. That gives you more agency than a purely inherited risk would, even where the job makes some of those patterns hard to change.

What screening is available, who qualifies, and where the system falls short for remote workers

The policy news is genuinely good, and recent. From 1 July 2024, the National Bowel Cancer Screening Programme (NBCSP) lowered its eligibility age, offering a free biennial immunochemical faecal occult blood test (iFOBT, a simple at-home stool test) to Australians aged 45-74, down from the previous 50 floor.

The NBCSP eligibility age reduction, confirmed by the Australian Department of Health and Aged Care, took effect on 1 July 2024, and the opt-in pathway for 45-49 year olds means eligibility is active now rather than something to revisit at a future birthday.

The mechanics differ by age band, and the distinction matters because it determines whether the kit comes to you or whether you have to ask.

For those with a moderately increased familial risk, the guidance goes further: biennial iFOBT from 40-49 and a colonoscopy every five years from 50-74. The point is that being under 50 does not lock you out. It changes the entry route.

Why FIFO and remote workers face compounding obstacles

Availability is not the same as participation, and this is where the system quietly fails the resources workforce. The single most common reason people give for not completing the kit is not cost or access. It is procrastination: 61% of non-completers said they “wanted to do it but did not get around to it.” The second is embarrassment or disgust at handling a stool sample, cited by 54%.

Layer on the practical realities of remote work. Transient mailing addresses mean the kit may never reach you. Long shifts and strict return-postage windows mean it expires in a drawer. On-site primary care is limited, and follow-up colonoscopies require travel most rosters do not accommodate. Indigenous Australians participate at 27%, against 43% for non-Indigenous Australians, a gap that maps closely onto remote and lower-access populations.

The interventions that work are targeted rather than generic: mobile screening in remote communities, and co-designed programmes using tailored coaching and peer champions, a model that translates directly to a mine site.

Early detection changes everything. When bowel cancer is caught early, nearly 99% of cases can be successfully treated. Yet younger patients typically wait up to 60% longer for a diagnosis than older patients, sometimes seeing multiple GPs before anyone suspects cancer.

That 61% procrastination figure is the one that should land hardest here. Nationally, the dominant barrier is not access or affordability. It is the deferral of something that does not feel urgent, which is precisely the health behaviour the resources workforce is most prone to.

What Josh Collins’s experience, and Melanie’s, reveals about how the resources sector approaches its own health

Return to Josh Collins, because the interesting part of his story is not the diagnosis. It is what came after.

Diagnosed at 36 in 2020, he completed treatment and, roughly two months later, rode a jet ski across open water to Rottnest Island at 99 km/h, then went a further 25 kilometres offshore, alone, to reach a fish aggregating device. He took his children on a coastal Western Australian road trip where his young son swam with a whale shark.

Read cynically, that looks like recklessness. Read accurately, it is a reordering of priorities that a cancer diagnosis forced on him. Facing mortality tends to expose the real cost of deferred living, and Josh’s response was to stop deferring.

The most revealing detail is smaller. When Josh received a mail-in screening kit, his reaction was enthusiasm. His peers found that reaction unusual.

The most diagnostic moment in the whole story. Josh’s genuine enthusiasm for a screening kit struck the people around him as strange. That reaction, from his peers rather than from him, is a real-time picture of how normalised health deferral has become in this workforce.

Melanie’s experience runs on a parallel track, but from the preventive side. After seeing a Goldfields billboard describing kidney disease as a silent illness, she booked a blood test that returned a low eGFR result, and she now monitors it actively. She uses social media to advocate for early detection, and one UK follower who reached remission from breast cancer told Melanie first, before anyone else.

Melanie also holds up her father as a warning. He deferred travel until retirement at 70, then developed sepsis and heart complications that left him unable to fulfil those plans across his final eight years.

Put the two accounts together and they stop being inspiration and become diagnosis. They illustrate the exact gap between what the data says, screen early and act early, and what the prevailing culture says, she’ll be right. For anyone in the resources sector, that mirror should be recognisable, because the “she’ll be right” instinct is precisely the behaviour that lets early-stage disease become late-stage disease.

Worker health advocacy in the Pilbara has accelerated in 2026, with unions pushing mine operators on physical safety standards; the same institutional pressure that has begun to move heat policy is the most plausible vehicle for shifting bowel cancer screening participation rates at site level.

What the data actually asks of anyone in this industry who is over 35

Strip away the statistics and the policy detail, and the practical question reduces to your age bracket and one decision.

1. If you are 45-74: The free iFOBT is yours by right. For 50-74, the kit arrives automatically. Do the test when it lands, and do not let it expire in a drawer.
2. If you are 45-49: The entitlement exists, but you have to claim it. Opt in through the NBCSP webform, by phone, or via your GP. This single request is the most actionable step available to you.
3. If you are 40-44: A conversation with your GP is the entry point. You can request an iFOBT through a healthcare professional, and a family history of bowel cancer or polyps strengthens the case.

The pattern working against all of this is deferral. In under-50s, time to diagnosis runs up to 60% longer than in older patients, and early detection carries a roughly 99% treatment success rate that late-stage detection does not. The cost of putting it off is measured in outcomes.

If you have spent more than a decade in this industry, the habit of parking non-urgent decisions is not a character flaw. It is a trained occupational reflex. Recognising it as a habit, rather than a fact of who you are, is the first step to overriding it for something that will not wait.

Josh and Melanie are not motivational bookends. They are evidence that the people best placed to shift the culture in this sector are already modelling the alternative.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions.